The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 482.00
Bid: 478.50
Ask: 482.50
Change: 13.00 (2.77%)
Spread: 4.00 (0.836%)
Open: 470.00
High: 483.50
Low: 465.00
Prev. Close: 469.00
IPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of fixed income assets

9 Jan 2024 07:35

RNS Number : 0083Z
Impax Asset Management Group plc
09 January 2024
 

Impax Asset Management Group plc

("Impax" or the "Company")

 

Impax to acquire fixed income assets and expand portfolio management team in agreement with Copenhagen-based Formuepleje

 

London, 9 January 2024 - Impax Asset Management Group plc, ("Impax"), the specialist asset manager investing in the transition to a more sustainable economy, announced today that its wholly owned subsidiary Impax Asset Management Ireland Limited ("Impax Ireland") has entered into an agreement to acquire the assets of Absalon Corporate Credit ("Absalon"), a fixed income manager, the completion of which is subject to certain closing conditions.

Absalon, which is part of the Formuepleje Group, based in Copenhagen, Denmark, serves European institutional investors and Danish high net worth individuals. As of 31 December 2023, Absalon had approximately £351 million (?405 million) of assets under management.

The Absalon team manages two fixed income strategies in Global High Yield (launched in 2006) and Emerging Market Corporate Debt (launched in 2010), which are available as Luxembourg-based SICAV funds ("SICAV Funds") and as Danish-based funds ("Danish Funds"). The team was established by Klaus Blaabjerg, who, along with three portfolio management colleagues, is joining Impax as part of the acquisition. Each member of the team has more than 15 years of experience and the team has worked together for more than 10 years.

Impax Ireland has entered into an asset purchase agreement with the Formuepleje Group, an existing client and distribution partner of Impax, with respect to the acquisition. The consideration is not disclosed.

Following completion of the acquisition, the Absalon portfolio managers will become part of Impax's growing fixed income team, reporting to Ross Pamphilon, who in October 2023 was appointed as Impax's Head of Fixed Income. The existing Impax fixed income team, which is based in the United States, currently runs US Investment Grade and US High Yield fixed income funds that are distributed to investors in North America. Post the acquisition, the combined global team will have pro forma fixed income assets under management and advice of approximately £1.6 billion (?1.8 billion) as of 31 December 2023.

Upon completion of the acquisition, it is planned that Impax Ireland, acting through a newly established Danish branch, will become the management company, investment manager and distributor of the former Absalon SICAV Funds, which are intended to become part of Impax's Ireland-based UCITS range. This is subject to SICAV Funds Board, shareholder and regulatory approval. Upon completion of the acquisition, and subject to fund shareholder and regulatory approval, it is also planned that Impax Ireland, acting through a newly established Danish branch, will become the sub-investment manager of the Danish Funds, for which Formuepleje will continue to act as the management company and distributor.

Ian Simm, Founder and Chief Executive, Impax, said: "This is an important step in the continued enhancement of our fixed income offering, which we have identified as a strategic priority as we aim to provide a wider range of solutions to our clients who are seeking to allocate to the transition to a more sustainable economy. The addition of this highly experienced team of credit managers, with a successful track record, will complement our existing fixed income capabilities, particularly in high yield. We value highly our 15-year relationship with Formuepleje, and we are delighted to use this opportunity to expand the partnership."

Klaus Blaabjerg, Managing Director, Absalon Corporate Credit, said: "We are excited by the opportunity to join the Impax team and leverage the firm's extensive resources dedicated to investing in the transition to a more sustainable economy. This is particularly important given that our funds are now categorized as Article 8 under SFDR. We believe that the credit markets are inefficient, which leaves many attractive opportunities for disciplined investors. We will continue to exploit these inefficiencies by actively selecting undervalued credits with high spreads relative to credit quality and default risk. We look forward to building on our successful track record and continuing to maintain our successful relationship with the Formuepleje team."

Peter Kjærgaard, CEO at Formuepleje, commented: "We are pleased to continue our close relationship with the Absalon Corporate Credit team through this agreement with Impax. Absalon Corporate Credit has a distinctive investment philosophy which is rooted in its academic research and the unique and experienced investment team. We look forward to continuing to provide their two strategies to our clients and as an integrated part of our funds."

Enquiries:

Impax Asset Management Group plc

Ian Simm, Chief Executive

Paul French, Head of Communications

 

 

+44 (0)20 3912 3000

+44 (0)20 3912 3032

Montfort Communications

Gay Collins

Jack Roddan

impax@montfort.london

 

 

+44 (0)77 9862 6282

+44 (0)78 2567 0695

Peel Hunt LLP, Nominated Adviser and Joint Broker

John Welch

Dan Webster

 

Berenberg, Joint Broker

James Felix

Dan Gee-Summons

 

+44 (0)20 7418 8900

 

 

+44 (0)20 3207 7800

 

About Absalon Corporate Credit

Absalon Corporate Credit is an investment management firm focused on credit, serving European institutional investors and Danish high net worth individuals. Based in Copenhagen, Denmark, it has approximately ?405 million of assets under management and advice (as of 31 December 2023) and is part of the Formuepleje Group. Absalon Corporate Credit has an active bottom-up bond selection philosophy. Looking beyond index weightings it instead focuses on identifying undervalued bonds irrespective of their sector or geography. The team manages two funds: Absalon Global High Yield and Absalon Emerging Markets Corporate Debt.

About Formuepleje

Formuepleje is one of Denmark's largest independent asset managers with more than 35 years of experience in developing optimal investment solutions. Our investment concept focuses on risk-adjusted returns. This means that we invest with the purpose to achieve the highest possible return with as little a risk as possible. The total amount of assets under management is more than ?9.1 billion and the customer base is around 18,000. Formuepleje employs more than 100 people in offices in Aarhus and Copenhagen.

About Impax

Founded in 1998, Impax is a specialist asset manager, with approximately £39.1 billion as of 31 December 2023 in both listed and private markets strategies, investing in the opportunities arising from the transition to a more sustainable global economy.

Impax believes that capital markets will be shaped profoundly by global sustainability challenges, including climate change, pollution and essential investments in human capital, infrastructure and resource efficiency. These trends will drive growth for well-positioned companies and create risks for those unable or unwilling to adapt.

The company seeks to invest in higher quality companies with strong business models that demonstrate sound management of risk. Impax offers a well-rounded suite of investment solutions spanning multiple asset classes seeking superior risk-adjusted returns over the medium to long term.

Impax has approximately 300 employees1 across its offices in the United Kingdom, the United States, Ireland, Hong Kong and Japan making it one of the investment management sector's largest investment teams dedicated to sustainable development.

www.impaxam.com

 

1 Full-time equivalent 

 

Issued in the UK by Impax Asset Management Group plc, whose shares are quoted on the Alternative Investment Market of the London Stock Exchange. Impax Asset Management Group plc is registered in England & Wales, number 03262305. AUM relates to Impax Asset Management Limited, Impax Asset Management (AIFM) Limited, Impax Asset Management Ireland Limited and Impax Asset Management LLC. Impax Asset Management Limited and Impax Asset Management (AIFM) Limited are authorised and regulated by the Financial Conduct Authority and are wholly owned subsidiaries of Impax Asset Management Group plc. Please note that the information provided on www.impaxam.com and links from it should not be relied upon for investment purposes. 

Impax is trademark of Impax Asset Management Group Plc. Impax is a registered trademark in the EU, US, Hong Kong and Australia. © Impax Asset Management LLC, Impax Asset Management Limited and/or Impax Asset Management (Ireland) Limited. All rights reserved.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUWOBRSRUARAR
Date   Source Headline
7th Jul 20217:00 amRNSQ3 AUM update
16th Jun 20217:00 amRNSHolding(s) in Company
27th May 20217:00 amRNSInterim results to 31 March 2021
25th May 20217:00 amRNSInterim Results Investor Presentation
24th May 20217:00 amRNSAppointment of Joint Broker
6th May 20217:00 amRNSDate of Interim Results
15th Apr 202110:21 amRNSDirector/PDMR Shareholding
12th Apr 20215:39 pmRNSHolding(s) in Company
12th Apr 20214:47 pmRNSDistribution agreements
9th Apr 20212:37 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20217:00 amRNSQ2 AUM update
18th Mar 20213:49 pmRNSResult of AGM
8th Mar 202112:15 pmRNSAnnual General Meeting arrangements
1st Mar 20217:00 amRNSTotal Voting Rights
17th Feb 20219:52 amRNSHolding(s) in Company
15th Feb 20217:00 amRNSFinalisation of Pax acquisition, Issue of Equity
8th Feb 20212:57 pmRNSDirector/PDMR Shareholding
8th Feb 202111:13 amRNSHolding(s) in Company
1st Feb 20215:58 pmRNSDirector/PDMR Shareholding
8th Jan 20217:00 amRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSQ1 AUM update
29th Dec 20203:00 pmRNSDirector/PDMR Shareholding
24th Dec 202011:54 amRNSHolding(s) in Company
22nd Dec 20203:39 pmRNSDirector/PDMR Shareholding
16th Dec 202012:26 pmRNSHolding(s) in Company
16th Dec 20207:00 amRNSDirector/PDMR Shareholding
15th Dec 20205:21 pmRNSNotice of Annual General Meeting
8th Dec 20207:00 amRNSDirectorate Change
7th Dec 20203:47 pmRNSDirector/PDMR Shareholding
4th Dec 202010:16 amRNSAnnual Financial Report
3rd Dec 20207:00 amRNSFinal Results
26th Nov 20207:00 amRNSNotice of Results
13th Nov 20205:22 pmRNSHolding(s) in Company
13th Nov 20205:18 pmRNSHolding(s) in Company
13th Nov 20207:00 amRNSHolding(s) in Company
11th Nov 20207:00 amRNSResults of secondary placing in Impax
10th Nov 20204:35 pmRNSProposed secondary placing in Impax
2nd Nov 20204:48 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSDistribution agreement
7th Oct 20207:00 amRNSAUM update
22nd Sep 20204:24 pmRNSHolding(s) in Company
18th Sep 202012:07 pmRNSSecond Price Monitoring Extn
18th Sep 202012:02 pmRNSPrice Monitoring Extension
20th Aug 20204:40 pmRNSSecond Price Monitoring Extn
20th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 202012:07 pmRNSSecond Price Monitoring Extn
18th Aug 202012:02 pmRNSPrice Monitoring Extension
11th Aug 202012:07 pmRNSSecond Price Monitoring Extn
11th Aug 202012:02 pmRNSPrice Monitoring Extension
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.